Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.

Bioscience reports - 31 Jul 2020

Liu Jun, Chen Zheng, Zhao Pingsen, Li Wenli

Abstract excerpt

The neurotransmitter, serotonin has emerged as a tumor growth factor and immune response regulator through complex signaling pathways. Yip1 Interacting Factor Homolog B (YIF1B) is a membrane protein involved in serotonin receptor (HTR) membrane trafficking and signal transmission in neuropathy. Participation of YIF1B in serotonin-induced tumor growth and immune regulation has not been previously investigated....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Datasets as Topic

Share to Kaplan-Meier Estimate

Share to Receptors, Serotonin

Share to Risk Assessment

Share to Serotonin

Share to Vesicular Transport Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 32648580
DOI: 10.1042/BSR20201384
PMCID: PMC7378310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.PMID 32648580Read ↗

Pan-cancer analysis of DEFB1 as a candidate prognostic biomarker and associated with immune infiltrationSemantic proximity Read ↗

Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarkerSemantic proximity Read ↗

KIF11 As a Potential Pan‐Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic ResponsesSemantic proximity Read ↗

Role of IQGAP1 in CarcinogenesisSemantic proximity Read ↗

YBX1 as a prognostic biomarker and potential therapeutic target in hepatocellular carcinoma: A comprehensive investigation through bioinformatics analysis and in vitro studySemantic proximity Read ↗

Breast cancer intrinsic YTHDF1 forms “cold” tumor and inhibits CD8+ T cells infiltration and functionSemantic proximity Read ↗

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer AnalysisSemantic proximity Read ↗

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-CancerSemantic proximity Read ↗

Pan-Cancer Analysis Identifies YTHDF2 as an Immunological and Prognostic BiomarkerSemantic proximity Read ↗

A Pan-Cancer Analysis of the KIF Family Gene and their Association with Prognosis, Tumor Microenvironment, and Therapeutic TargetsSemantic proximity Read ↗

SREBF1 is a Potential Prognostic and Immunological Biomarker in Pan-CancerSemantic proximity Read ↗

Pancancer analysis of the interactions between CTNNB1 and infiltrating immune cell populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.